Procalcitonin as a diagnostic marker and IL-6 as a prognostic marker for sepsis

Diagnostic Microbiology and Infectious Disease

Volumn 75, Issue 4, 2013, Pages 342-347

  Jekarl, Dong Wook ^a   Lee, So Young ^a   Lee, Jehoon ^a   Park, Yeon Joon ^a   Kim, Yonggoo ^a   Park, Jeong Ho ^a   Wee, Jung Hee ^a   Choi, Seung Pill ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

C reactive protein; Interleukin 6; Procalcitonin; Sepsis; Systemic inflammatory response syndrome

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; INTERLEUKIN 6; PROCALCITONIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DRUG EFFICACY; ERYTHROCYTE SEDIMENTATION RATE; ESCHERICHIA COLI; FEMALE; FOLLOW UP; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SEPSIS; SEPTIC SHOCK; SURVIVAL RATE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTERIAL INFECTIONS; BIOLOGICAL MARKERS; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; CALCITONIN; COHORT STUDIES; FEMALE; HUMANS; INTERLEUKIN-6; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; SENSITIVITY AND SPECIFICITY; SEPSIS; YOUNG ADULT;

EID: 84875257561     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2012.12.011     Document Type: Article

References (25)

1. Assicot M., Gendrel D., Carsin H., et al. High serum procalcitonin concentration in patients with sepsis and infection. Lancet 1993, 341:515-518.
2. Bone R., Balk R., Cerra F.B., Dellinger R., Fein A., Knaus W., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992, 101:1644-1655.
3. Brunkhorst F.M., Wegscheider K., Forycki Z.F., et al. Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis and septic shock. Intensive Care Med 2000, 26:S148-S152.
4. Chalupa P., Beran O., Herwald H., Kasprikova N., Holub M. Evaluation of potential biomarkers for the discrimination of bacterial and viral infections. Infection 2011, 39:411-417.
5. Chan Y.L., Tseng C.P., Tsay P.K., et al. Procalcitonin as a marker of bacterial infection in the emergency department: an observational study. Crit Care 2004, 8:R11-R20.
6. Claessens Y.E., Mathevon T., Kierzek G., et al. Accuracy of C-reactive protein, procalcitonin, and mid-regional pro-atrial natriuretic peptide to guide site of care of community-acquired pneumonia. Intensive Care Med 2010, 36:799-809.
7. Clec'h C., Ferrier F., Karoubi P., et al. Diagnostic and prognostic value of procalcitonin in patients with septic shock. Crit Care Med 2004, 32:1166-1169.
8. Elefsiniotis I., Petrocheilou A., Scarmeas N., et al. Serum procalcitonin levels in chronic hepatitis C patients under pegylated interferon-alpha plus ribavirin treatment. J Clin Virol 2006, 37:329-331.
9. Fariñas-Alvarez C., Fariñas M.C., Fernández-Mazarrasa C., et al. Epidemiological differences between sepsis syndrome with bacteremia and culture-negative sepsis. Infect Control Hosp Epidemiol 2002, 21:639-644.
10. Gaini S., Koldkjaer O.G., Pedersen C., et al. Procalcitonin, lipopolysaccharide-binding protein, interleukin-6 and C-reactive protein in community-acquired infections and sepsis: a prospective study. Crit Care 2006, 10:R53.
11. Georgopoulou A.P., Savva A., Giamarellos-Bourboulis E.J., et al. Early changes of procalcitonin may advise about prognosis and appropriateness of antimicrobial therapy in sepsis. J Crit Care 2011, 26:331e1-331e7.
12. Giamarellos-Bourboulis E.J., Mega A., Grecka P., et al. Procalcitonin: a marker to clearly differentiate systemic inflammatory response syndrome and sepsis in the critically ill patient?. Intensive Care Med 2002, 28:1351-1356.
13. Guven H., Altintop L., Baydin A., et al. Diagnostic value of procalcitonin levels as an early indicator of sepsis. Am J Emerg Med 2001, 20:202-206.
14. Hausfater P., Garric S., Ayed B., et al. Usefulness of procalcitonin as a marker of systemic infection in emergency department patients: a prospective study. Clin Infect Dis 2002, 34:895-901.
15. Hausfater P., Juillien G., Madonna-Py B., et al. Serum procalcitonin measurement as diagnostic and prognostic marker in febrile adult patients presenting to the emergency department. Crit Care 2007, 11:R60.
16. Jensen J.U., Heslet L., Jensen T.M., et al. Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Crit Care Med 2006, 34:2596-2602.
17. Labelle A.J., Arnold H., Reichle R., et al. A comparison of culture-positive and culture-negative health-care-associated pneumonia. Chest 2010, 137:1130-1137.
18. Lipinska-Gediga M., Mierzchala M., Durek G. Pro-arterial natriuretic peptide (pro-ANP) level in patients with severe sepsis and septic shock: prognostic and diagnostic significance. Infection 2012, 40:303-309.
19. Martin G., Mannino D., Eaton S., et al. The epidemiology of sepsis in the United Sates from 1979 through 2000. N Engl J Med 2003, 348:1546-1554.
20. Meisner M., Tschaikowsky K., Palmaers T., Schmidt J. Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the courses of sepsis and MODS. Crit Care 1999, 1:45-50.
21. Park J.H., Wee J.H., Choi S.P., et al. The value of procalcitonin level in community-acquired pneumonia in the ED. Am J Emerg Med 2011, [in print].
22. Reinhart K., Meisner M. Biomarkers in the critically ill patient: procalcitonin. Crit Care Clin 2011, 27:253-263.
23. Schroder J., Staubach K.H., Zabel P., et al. Procalcitonin as a marker of severity in septic shock. Langenbeck's Arch Surg 1999, 384:33-38.
24. Suprin E., Camus C., Gacouin A., et al. Procalcitonin: a valuable indicator of infection in a medical ICU?. Intensive Care Med 2000, 26:1232-1238.
25. Tang B., Eslick G., Craig J., et al. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis 2007, 7:210-217.